Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.

about

Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.

Item

http://www.wikidata.org/entity/Q38392598

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.

@en

type

Item

label

Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.

@en

prefLabel

Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.

@en

P1476

Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure

@en

P2093

Guido Grassi

http://www.w3.org/2001/XMLSchema#string

P2860

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

Sympathetic activation in the pathogenesis of hypertension and progression of organ damage.

The sympathetic system and hypertension.

Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations.

Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.

Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.

Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?

P2888

s40292-015-0083-6

P304

233-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40292-015-0083-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gino Seravalle

P577

2015-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25813853

http://www.w3.org/2001/XMLSchema#string